Cargando…
Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases
BACKGROUND: Patients with desmoplastic (angiogenic) histopathological growth pattern (HGP) colorectal liver metastases (CLM) might derive more benefit from bevacizumab-based chemotherapy than those with replacement (non-angiogenic) HGP. This study investigated the association of HGP with the immune...
Autores principales: | Stremitzer, Stefan, Vermeulen, Peter, Graver, Shannon, Kockx, Mark, Dirix, Luc, Yang, Dongyun, Zhang, Wu, Stift, Judith, Wrba, Friedrich, Gruenberger, Thomas, Lenz, Heinz-Josef, Scherer, Stefan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217855/ https://www.ncbi.nlm.nih.gov/pubmed/32205863 http://dx.doi.org/10.1038/s41416-020-0812-z |
Ejemplares similares
-
DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells
por: Laengle, Johannes, et al.
Publicado: (2018) -
Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers
por: Bohlok, Ali, et al.
Publicado: (2023) -
Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer
por: Sebio, Ana, et al.
Publicado: (2015) -
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases
por: Galjart, Boris, et al.
Publicado: (2019) -
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study
por: Piringer, Gudrun, et al.
Publicado: (2023)